Renal mucormycosis in post-COVID patients in Australia

Matthew Chau; Nicole Swarbrick; Jennifer Kong

doi:10.1016/j.eucr.2023.102353

Renal mucormycosis in post-COVID patients in Australia

Urol Case Rep. 2023 Mar:47:102353. doi: 10.1016/j.eucr.2023.102353. Epub 2023 Feb 14.

Authors

Matthew Chau¹, Nicole Swarbrick^{2

3}, Jennifer Kong¹

Affiliations

¹ Department of Urology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
² Department of Anatomical Pathology, PathWest Laboratory Medicine, Perth, WA, Australia.
³ Division of Pathology and Laboratory Medicine, Medical School, University of Western Australia, Perth, WA, Australia.

Abstract

Renal mucormycosis is a rare entity that has been described with significant associated morbidity and mortality. It is an opportunistic infection affecting immunocompromised patients. With the pandemic of COVID-19, we report the first case of renal mucormycosis in Australia secondary to COVID-19 and its management.

Publication types

Case Reports